Golden State Equity Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $459K | Sell |
875
-571
| -39% | -$300K | 0.09% | 260 |
|
|
2025
Q1 | $917K | Buy |
1,446
+88
| +6% | +$55.8K | 0.18% | 141 |
|
|
2024
Q4 | $967K | Buy |
1,358
+1,272
| +1,479% | +$906K | 0.18% | 134 |
|
|
2024
Q3 | $90.4K | Buy |
+86
| New | +$90.4K | 0.05% | 292 |
|
|
2021
Q3 | – | Sell |
-558
| Closed | -$312K | – | 268 |
|
|
2021
Q2 | $312K | Buy |
+558
| New | +$312K | 0.12% | 171 |
|